Institute Catalá Oncología -ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2020

  1. First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors

    Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042

2019

  1. Enhanced antitumor efficacy of oncolytic adenovirus–loaded menstrual blood–derived mesenchymal stem cells in combination with peripheral blood mononuclear cells

    Molecular Cancer Therapeutics, Vol. 18, Núm. 1, pp. 127-138

2018

  1. Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice

    Cancer Immunology, Immunotherapy, Vol. 67, Núm. 10, pp. 1589-1602

2017

  1. Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus

    Stem Cells International, Vol. 2017

2016

  1. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells

    Cancer Letters, Vol. 371, Núm. 2, pp. 161-170

2010

  1. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: An exploratory study

    Cancer Gene Therapy, Vol. 17, Núm. 7, pp. 476-483

2008

  1. Cancer genes hypermethylated in human embryonic stem cells

    PLoS ONE, Vol. 3, Núm. 9

2005

  1. Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors

    Cancer Gene Therapy, Vol. 12, Núm. 4, pp. 341-349